Products

Medicure is a pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

We Bring Medicine to Life.

The product information provided below is intended for residents of the U.S. only. To report an adverse event or a product complaint, or to request information about our products, please visit our Drug Safety or Medical Information pages.

AGGRASTAT (tirofiban hydrochloride) for injection

Following approval of a new dosing regimen in 2013, AGGRASTAT is the most widely used glycoprotein inhibitor in the United States. See Aggrastat Patents.

Full Prescribing Information

Aggrastat Page

ZYPITAMAG (pitavastatin) tablets

ZYPITAMAG is a statin (HMG-CoA reductase inhibitor) medication approved by the U.S. Food and Drug Administration (FDA) in July 2017. See Zypitamag Patents.

Full Prescribing Information

Zypitamag Patient Website

Zypitamag Healthcare Professionals Website